References
- Sonnenberg A, Everhart JE. Health impact of peptic ulcer in the United States. Am J Gastroenterol 1997;92:614–20.
- Corinaldesi R, De Giorgio R, Paternico A, Stanghellini V. Asymptomatic peptic ulcer disease. Is it worth looking for? Drugs 1991;41:821–4.
- Wilcox CM, Clark WS. Features associated with painless peptic ulcer bleeding. Am J Gastroenterol 1997;92:1289–92.
- Lu CL, Chang SS, Wang SS, Chang FY, Lee SD. Silent peptic ulcer disease: frequency, factors leading to "silence," and implications regarding the pathogenesis of visceral symptoms. Gastrointest Endosc 2004;60:34–8.
- Wang FW, Tu MS, Mar GY, Chuang HY, Yu HC, Cheng LC, et al. Prevalence and risk factors of asymptomatic peptic ulcer disease in Taiwan. World journal of gastroenterology : WJG 2011;17:1199–203.
- Lu CL, Chen CY, Lang HC, Luo JC, Wang SS, Chang FY, et al. Current patterns of irritable bowel syndrome in Taiwan: the Rome II questionnaire on a Chinese population. Alimentary pharmacology & therapeutics 2003;18:1159–69.
- Corazziari E. New Rome criteria for functional gastrointestinal disorders. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2000;32:S233–4.
- Gao YT, McLaughlin JK, Blot WJ, Ji BT, Benichou J, Dai Q, et al. Risk factors for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking. Int J Cancer 1994;58:192–6.
- Hilton D, Iman N, Burke GJ, Moore A, O'Mara G, Signorini D, et al. Absence of abdominal pain in older persons with endoscopic ulcers: a prospective study. Am J Gastroenterol 2001;96:380–4.
- Lanza FL. A review of gastric ulcer and gastroduodenal injury in normal volunteers receiving aspirin and other non-steroidal anti-inflammatory drugs. Scandinavian journal of gastroenterology supplement 1989;163:24–31.
- Chan FK, Abraham NS, Scheiman JM, Laine L. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents. Am J Gastroenterol 2008;103:2908–18.
- Soll AH. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. JAMA 1996;275:622–9.
- Pounder R. Silent peptic ulceration: deadly silence or golden silence? Gastroenterology 1989;96:626–31.
- Clinch D, Banerjee AK, Ostick G. Absence of abdominal pain in elderly patients with peptic ulcer. Age Ageing 1984;13:120–3.
- Dew MJ. Asymptomatic peptic ulcer disease. Br Med J (Clin Res Ed) 1987;295:401.
- Mellem H, Stave R, Myren J, Osnes M, Hanssen LE, Mosvold J, et al. Symptoms in patients with peptic ulcer and hematemesis and/or melena related to the use of non-steroid anti-inflammatory drugs. Scand J Gastroenterol 1985;20:1246–8.
- Kato-Tsukada S, Nakamura T. [Peptic ulcer in the elderly–general considerations, definition and classification]. Nihon rinsho Japanese journal of clinical medicine 2002;60:1483–9.
- Kato I, Nomura AM, Stemmermann GN, Chyou PH. A prospective study of gastric and duodenal ulcer and its relation to smoking, alcohol, and diet. Am J Epidemiol 1992;135:521–30.
- Stack WA, Atherton JC, Hawkey GM, Logan RF, Hawkey CJ. Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding. Alimentary pharmacology & therapeutics 2002;16:497–506.
- Rosenstock S, Jorgensen T, Bonnevie O, Andersen L. Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults. Gut 2003;52:186–93.